Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK's Verona £44.7m Capital Raising To Be Followed By NASDAQ Listing

Executive Summary

Verona Pharma PLC‘s capital raising will allow the Cardiff, UK-based biotech to progress its lead respiratory compound RPL554 through to a Phase III ready stage and sets the scene for a NASDAQ listing in the first quarter of 2017.

Advertisement

Related Content

After Tocagen Thaws IPO Freeze, Verona And Zymeworks Bring April Total To Three

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC065454

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel